These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 9376765
21. [The role of monoamin- and acidergic mechanisms of the hippocampus in anxiety states of different origins and their participation in the antiaversive effects of anxiolytics]. Talalaenko AN, Krivobok GK, Stakhovskiĭ IuV. Fiziol Zh Im I M Sechenova; 1993 Jan; 79(1):99-104. PubMed ID: 8100168 [Abstract] [Full Text] [Related]
22. [Functional significance of monoamine- and aminoacidergic mechanisms of dorsal pallidum in anxiety of different aversive genesis]. Talalaenko AN, Krivobok GK, Bulgakova NP, Pankrat'ev DV. Zh Vyssh Nerv Deiat Im I P Pavlova; 2007 Jan; 57(1):86-90. PubMed ID: 17432321 [Abstract] [Full Text] [Related]
27. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Stachowicz K, Chojnacka-Wójcik E, Kłak K, Pilc A. Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774 [Abstract] [Full Text] [Related]
29. [Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models]. Talalaenko AN, Pankrat'ev DV, Goncharenko NV. Ross Fiziol Zh Im I M Sechenova; 2001 Sep; 87(9):1217-26. PubMed ID: 11763535 [Abstract] [Full Text] [Related]
30. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic. Dubinsky B, Vaidya AH, Rosenthal DI, Hochman C, Crooke JJ, DeLuca S, DeVine A, Cheo-Isaacs CT, Carter AR, Jordan AD, Reitz AB, Shank RP. J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665 [Abstract] [Full Text] [Related]
34. The microinjection of AMPA receptor antagonist into the accumbens shell failed to change food intake, but reduced fear-motivated behaviour in free-feeding female rats. da Cunha IC, de Nazareth AM, Vargas JC, Ferraz A, Neto JM, Paschoalini MA, Faria MS. Behav Brain Res; 2008 Nov 21; 193(2):243-7. PubMed ID: 18586053 [Abstract] [Full Text] [Related]
37. The role of dopaminergic mechanisms on the brain in various models of anxious states. Talalaenko AN, Abramets IA, Stakhovskii YuV, Shekhovtsov AA, Chernikov AV, Shevchenko SL. Neurosci Behav Physiol; 1994 Nov 21; 24(3):284-8. PubMed ID: 7969883 [Abstract] [Full Text] [Related]
40. [Correlation between the experimental and clinical effectiveness of benzodiazepines and their affinity for benzodiazepine receptors]. Rudenko GM, Voronina TA, Shatrova NG, Chepelev VM. Biull Eksp Biol Med; 1982 Aug 21; 94(8):54-6. PubMed ID: 6127125 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]